Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews' Q3 Revenues Rise Sharply on Royalties

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews today reported a 258 percent rise year over year in third-quarter revenues.

Revenues in the quarter increased to C$157,692 (US$157,446) from C$43,999 as royalty revenues climbed to C$154,238, compared to none a year ago, the Toronto-based firm said in a document filed with Canadian Securities Administrators. Sales were down to C$3,454 from C$8,210, and milestone revenues dropped to zero from C$35,789 a year ago.

The firm's R&D costs increased 36 percent year over year to C$551,838 from C$406,813, and SG&A costs rose 76 percent to C$853,565 from C$485,788.

GeneNews' net loss in the quarter was C$1.4 million, or C$.01 per share, compared to a net loss of C$997,835, or C$.01 per share, a year ago.

The company exited the third quarter with C$2.1 million in cash and short-term investments.

In September it announced a deal with Shanghai Biochip to establish a center to co-develop and commercialize products based on GeneNews' gene expression technology. As part of the deal, SBC was given non-exclusive rights to market GeneNews' ColonSentry, a blood-based colon cancer stratification test.

The company launched the test in the US through its marketing partner Enzo Clinical labs in April, and GeneNews' President and COO Gailina Liew said in a statement today that interest from doctors and patients in the test has been positive.

"As efforts directed at an expanded launch continue, we look forward to increasing market presence and growing revenues," she said.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.